Article info
Therapeutics
Randomised controlled trial
Evidence suggests dabigatran is an effective and safe treatment for patients with VTE requiring early parenteral therapy
- Correspondence to : Dr Alexander T Cohen, Department of Thrombosis and Haemostasis, Guy's and St Thomas’ Hospitals, Westminster Bridge Road, London SE1 7EH, UK; alexander.cohen{at}kcl.ac.uk
Citation
Evidence suggests dabigatran is an effective and safe treatment for patients with VTE requiring early parenteral therapy
Publication history
- First published May 16, 2014.
Online issue publication
September 15, 2014
Article Versions
- Previous version (16 May 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions